Aino Health AB (publ) (FRA:50V)
Germany · Delayed Price · Currency is EUR 0.0355
+0.0315 (787.50%)
At close: Dec 1, 2025
Aino Health AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Operating Revenue | 26.69 | 23.94 | 23.92 | 19.91 | 23.04 | 24.92 | Upgrade |
Other Revenue | - | - | - | - | - | 0.52 | Upgrade |
| 26.69 | 23.94 | 23.92 | 19.91 | 23.04 | 25.44 | Upgrade | |
Revenue Growth (YoY) | 10.02% | 0.09% | 20.15% | -13.61% | -9.40% | -1.69% | Upgrade |
Cost of Revenue | 19.16 | 19.78 | 20.12 | 20.5 | 21.34 | 25.77 | Upgrade |
Gross Profit | 7.52 | 4.16 | 3.8 | -0.59 | 1.7 | -0.34 | Upgrade |
Selling, General & Admin | 9.58 | 10.33 | 10.14 | 10.89 | 13.08 | 10.42 | Upgrade |
Other Operating Expenses | 0.02 | 0.09 | 1.33 | 0.2 | 0.06 | 0.36 | Upgrade |
Operating Expenses | 12.54 | 13.41 | 14.46 | 13.97 | 15.93 | 13.66 | Upgrade |
Operating Income | -5.02 | -9.25 | -10.67 | -14.56 | -14.23 | -14 | Upgrade |
Interest Expense | -0.15 | - | - | - | -1.3 | -1.29 | Upgrade |
Interest & Investment Income | 0 | 0 | 0 | - | 0.26 | 2.11 | Upgrade |
Currency Exchange Gain (Loss) | 0.12 | 0.12 | 1.1 | 0.39 | 0.06 | 0.02 | Upgrade |
Other Non Operating Income (Expenses) | -0.84 | -0.79 | -1.1 | -0.8 | - | - | Upgrade |
Pretax Income | -5.88 | -9.92 | -10.66 | -14.96 | -15.22 | -13.17 | Upgrade |
Net Income | -5.88 | -9.92 | -10.66 | -14.96 | -15.22 | -13.17 | Upgrade |
Net Income to Common | -5.88 | -9.92 | -10.66 | -14.96 | -15.22 | -13.17 | Upgrade |
Shares Outstanding (Basic) | 160 | 99 | 55 | 41 | 25 | 19 | Upgrade |
Shares Outstanding (Diluted) | 160 | 99 | 55 | 41 | 25 | 19 | Upgrade |
Shares Change (YoY) | 41.55% | 80.83% | 33.82% | 61.53% | 34.87% | 23.13% | Upgrade |
EPS (Basic) | -0.04 | -0.10 | -0.19 | -0.37 | -0.60 | -0.70 | Upgrade |
EPS (Diluted) | -0.04 | -0.10 | -0.19 | -0.37 | -0.60 | -0.70 | Upgrade |
Free Cash Flow | -1.38 | -4.55 | -6.26 | -12.87 | -8.11 | -12.07 | Upgrade |
Free Cash Flow Per Share | -0.01 | -0.05 | -0.11 | -0.31 | -0.32 | -0.64 | Upgrade |
Gross Margin | 28.18% | 17.37% | 15.88% | -2.97% | 7.38% | -1.32% | Upgrade |
Operating Margin | -18.81% | -38.64% | -44.59% | -73.12% | -61.76% | -55.04% | Upgrade |
Profit Margin | -22.05% | -41.42% | -44.57% | -75.16% | -66.05% | -51.76% | Upgrade |
Free Cash Flow Margin | -5.18% | -19.00% | -26.18% | -64.66% | -35.21% | -47.45% | Upgrade |
EBITDA | -3.04 | -7.23 | -8.63 | -12.65 | -12.4 | -12.08 | Upgrade |
EBITDA Margin | -11.40% | -30.18% | -36.08% | -63.52% | -53.81% | -47.49% | Upgrade |
D&A For EBITDA | 1.98 | 2.03 | 2.04 | 1.91 | 1.83 | 1.92 | Upgrade |
EBIT | -5.02 | -9.25 | -10.67 | -14.56 | -14.23 | -14 | Upgrade |
EBIT Margin | -18.81% | -38.64% | -44.59% | -73.12% | -61.76% | -55.04% | Upgrade |
Revenue as Reported | 23.99 | 23.99 | 25.07 | 20.05 | 23.1 | 25.46 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.